A comprehensive investigation of this variant and potential therapeutic treatments was recently published [25]
AOMs known as anti-obesity medications, can be recommended as an additional therapy for a patient who does not achieve the goal of losing weight with a comprehensive weight loss program, such as losing 5% of the initial weight during 3-6 months
Clinical trials are underway for melanoma, non-small cell lung cancer, and other solid tumors
Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr
Targeting the PANoptosis pathways in NAFLD/NASH PANoptosis, a newly identified form of RCD, has garnered significant attention recently
A phase II randomized placebo-controlled study of dutasteride versus finasteride showed that the effect of dutasteride was dose dependent and 2.5mg of dutasteride was superior to 5mg finasteride in improving scalp hair growth in men between the ages of 21 and 45 years (184)